Literature DB >> 18164007

Missed injury and the tertiary trauma survey.

Charles B Thomson1, Ian Greaves.   

Abstract

Missed injury in the context of major trauma remains a persistent problem, both from a clinical and medico-legal point-of-view. Estimates of the incidence vary widely, dependent on the precise parameters of the studied population, the definition of missed injury and the extent of follow-up, but may be as high as 38%. The tertiary survey, in which formal repeated examination of the patient is undertaken after initial resuscitation and treatment have taken place, has been suggested as a way of identifying injuries not found at presentation. This paper appraises the concept of the tertiary survey, and also reviews the literature on missed injury in order to identify the risk factors, the types of injury and the reasons for error.

Entities:  

Mesh:

Year:  2007        PMID: 18164007     DOI: 10.1016/j.injury.2007.07.030

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  11 in total

1.  Tertiary survey performance in a regional trauma hospital without a dedicated trauma service.

Authors:  Gerben B Keijzers; Don Campbell; Jeffrey Hooper; Nerolie Bost; Julia Crilly; Michael Craig Steele; Blake Eddington; Leo M G Geeraedts
Journal:  World J Surg       Date:  2011-10       Impact factor: 3.352

2.  High delayed and missed injury rate after inter-hospital transfer of severely injured trauma patients.

Authors:  Riquard Lesley Hensgens; Mostafa El Moumni; Frank F A IJpma; Jorrit S Harbers; Kaj Ten Duis; Klaus W Wendt; Geertje A M Govaert
Journal:  Eur J Trauma Emerg Surg       Date:  2019-08-09       Impact factor: 3.693

3.  Delays in diagnosis in early trauma care: evaluation of diagnostic efficiency and circumstances of delay.

Authors:  M Muhm; T Danko; K Schmitz; H Winkler
Journal:  Eur J Trauma Emerg Surg       Date:  2011-07-07       Impact factor: 3.693

4.  Predictors of missed injuries in hospitalized trauma patients in the emergency department.

Authors:  M Emet; A Saritas; H Acemoglu; S Aslan; Z Cakir
Journal:  Eur J Trauma Emerg Surg       Date:  2010-04-14       Impact factor: 3.693

5.  The yield of tertiary survey in patients admitted for observation after trauma.

Authors:  Gijs Jacob Jan van Aert; Jelle Corneel van Dongen; Niels Cornelis Adrianus Sebastianus Berende; Hendrikus Gerardus Wilhelmus de Groot; Pieter Boele van Hensbroek; Philip Marcel Jozef Schormans; Dagmar Isabella Vos
Journal:  Eur J Trauma Emerg Surg       Date:  2020-09-05       Impact factor: 3.693

6.  Demographics, mechanism of injury, and associated injuries of 25,615 patients with talus fractures in the National Trauma Data Bank.

Authors:  Nidharshan S Anandasivam; Paul Bagi; Nathaniel T Ondeck; Anoop R Galivanche; Lovemore S Kuzomunhu; Andre M Samuel; Daniel D Bohl; Jonathan N Grauer
Journal:  J Clin Orthop Trauma       Date:  2019-06-08

7.  What is the effect of a formalised trauma tertiary survey procedure on missed injury rates in multi-trauma patients? Study protocol for a randomised controlled trial.

Authors:  Gerben B Keijzers; Chris Del Mar; Leo M G Geeraedts; Joshua Byrnes; Elaine M Beller
Journal:  Trials       Date:  2015-05-13       Impact factor: 2.279

8.  Detection of fractures of hand and forearm in whole-body CT for suspected polytrauma in intubated patients.

Authors:  F Münn; R A Laun; A Asmus; R Bülow; S Bakir; L Haralambiev; A Eisenschenk; S Kim
Journal:  BMC Musculoskelet Disord       Date:  2020-01-22       Impact factor: 2.362

9.  A Fact-Finding Procedure Integrating Machine Learning and AHP Technique to Predict Delayed Diagnosis of Bladder Patients with Hematuria.

Authors:  Chia-Lun Lo; Ya-Hui Yang; Hsiao-Ting Tseng
Journal:  J Healthc Eng       Date:  2021-08-21       Impact factor: 2.682

10.  Detection of missed fractures of hand and forearm in whole-body CT in a blinded reassessment.

Authors:  S Kim; L Goelz; F Münn; D Kim; M Millrose; A Eisenschenk; S Thelen; M Lautenbach
Journal:  BMC Musculoskelet Disord       Date:  2021-06-26       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.